FundedIQ
Biotechnology

Piedmont Stone Center: Funding, Investors & Team (Sep 2026)

Extracorporal Shock Wave Lithotripsy (ESL), a non-surgical method of treating kidney stones, is used by Piedmont Stone Center at many medical facilities spread out across locations in North Carolina and Virginia.

piedmontstonecenter.com LinkedIn Winston Salem, United States 11-50 employees
Biotechnology Health Care Health Diagnostics Medical
Total raised
$310k
Rounds
1
Latest
Seed
Jan 2023

Piedmont Stone Center has raised $310k across 1 funding round on record, the most recent a Seed of $310k announced in Jan 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Piedmont Stone Center Company Profile and Key Stats

Total funding raised
$310k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$310k in Jan 2023
Employees
11-50
reported band
Headquarters
Winston Salem, United States

Latest funding round on record: Jan 2023.

Piedmont Stone Center Funding Rounds

Date
Round
Amount
Seed
$310k

Piedmont Stone Center Founders and Leadership Team

Name
Role
Contact
Charles Hauser
CEO
Locked

Contact details for the Piedmont Stone Center team: 1 of 1 has an email address on file.

Start 14-day free trial →

Piedmont Stone Center Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
16,575
$3.1M

Piedmont Stone Center's latest round of $310k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Piedmont Stone Center in Biotechnology and Winston Salem

Companies Similar to Piedmont Stone Center

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Piedmont Stone Center Funding FAQs

What does Piedmont Stone Center do?

Extracorporal Shock Wave Lithotripsy (ESL), a non-surgical method of treating kidney stones, is used by Piedmont Stone Center at many medical facilities spread out across locations in North Carolina and Virginia.

How much funding has Piedmont Stone Center raised?

Piedmont Stone Center has raised $310k across 1 round on record. The most recent is a Seed of $310k announced in Jan 2023.

When did Piedmont Stone Center last raise funding?

Piedmont Stone Center's most recent funding round on record is a Seed of $310k, announced in Jan 2023.

Who is the CEO of Piedmont Stone Center?

Charles Hauser is listed as CEO at Piedmont Stone Center.

Where is Piedmont Stone Center headquartered?

Piedmont Stone Center is based in Winston Salem, North Carolina, United States.

How many employees does Piedmont Stone Center have?

Piedmont Stone Center is in the 11-50 employee band.

How does Piedmont Stone Center's funding compare to other Biotechnology startups?

Piedmont Stone Center's latest round of $310k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Piedmont Stone Center Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Piedmont Stone Center is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.